Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000284301 | SCV000404071 | uncertain significance | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000339102 | SCV000404072 | uncertain significance | Osteogenesis Imperfecta, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000391151 | SCV000404073 | uncertain significance | Infantile cortical hyperostosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549710 | SCV004749851 | likely benign | COL1A1-related disorder | 2021-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |